Cited by 2,120Alzheimer's disease research and treatmentsTrace Elements in HealthDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 71 of the 72 references it cites were found in a registry or an index.

Copper, iron and zinc in Alzheimer's disease senile plaques

Lovell, M.A, Robertson, J.D, Teesdale, W.J, Campbell, J.L, Markesbery, W.R·1998·Journal of the Neurological Sciences

DOI 10.1016/s0022-510x(98)00092-6

Open this paper in CoChat — free account

Abstract

Concentrations of copper (Cu), iron (Fe) and zinc (Zn) were measured in the rims and cores of senile plaques (SP) and in the neuropil of the amygdala of nine Alzheimer's disease (AD) patients and in the neuropil of the amygdala of five neurologically normal control subjects using micro particle-induced X-ray emission (micro-PIXE). Comparison of SP rim and core values revealed no significant differences between levels of Cu, Fe or Zn. Zinc and Fe in SP rims and cores were significantly elevated in AD compared with AD neuropil (P<0.05). Copper was significantly elevated (P<0.05) in the rim of SP compared with AD neuropil. Comparison of AD and control neuropil revealed a significant (P<0.05) elevation of Zn in AD subjects. The elevation of these elements in SP in AD is of interest in light of the observation that Cu, Fe and particularly Zn, can accelerate aggregation of amyloid beta peptide.

Integrity signals

Registry

Crossref · 10.1016/s0022-510x(98)00092-6

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
Oxidative stress hypothesis in Alzheimer’s disease
Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383
Self-citation
Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported
Evans, D. A. (1989) · JAMA · doi:10.1001/jama.262.18.2551 · Cited by 1,627
Rapid induction of Alzheimer A beta amyloid formation by zinc
Bush, A., Pettingell, W., Multhaup, G., d Paradis, M., Vonsattel, J., Gusella, J., Beyreuther, K., Masters, C., & Tanzi, R. (1994) · Science · doi:10.1126/science.8073293 · Cited by 1,522
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296
Self-citation
Release of endogenous Zn2+ from brain tissue during activity
Assaf, S. Y., & Chung, S. (1984) · Nature · doi:10.1038/308734a0 · Cited by 1,113
A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.
Hensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., & Butterfield, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3270 · Cited by 1,086

Show all 72 references

Research works printed but not linked: 3

Ben-Shachar, 1987, Dopamine D2 receptor modulation by brain non-haem iron, Br J Pharmacol, 90, 2P
Hess, 1974, Chronische Bleivergiftung. Praxis, 63, 177
Markesbery WR, Ehmann WD. Brain trace elements in Alzheimer disease. In: Terry RD, Katzman R, Bick KL, editors. Alzheimer disease. New York: Raven Press, 1994:353–67.

Sorted by citations

Items 801–900 of 1,007

Delivery of Curcumin and Medicinal Effects of the Copper(II)-Curcumin Complexes
Leung, M. H. M., Harada, T., & Kee, T. W. (2013) · Current Pharmaceutical Design · doi:10.2174/138161213805289237 · Cited by 51
Disturbed Copper Bioavailability in Alzheimer′s Disease
Kaden, D., Bush, A. I., Danzeisen, R., Bayer, T. A., & Multhaup, G. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/345614 · Cited by 51
Effects of aluminum on amyloid-beta aggregation in the context of Alzheimer’s disease
Zhang, Q., Zhang, F., Ni, Y., & Serge Kokot, A. (2015) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2015.06.019 · Cited by 51
Concepts for the treatment of Alzheimer's disease: molecular mechanisms and clinical application
Pietrzik, C. U., & Behl, C. (2005) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2005.00435.x · Cited by 52
Relevant activities of extracts and constituents of animals used in traditional Chinese medicine for central nervous system effects associated with Alzheimer's disease
Ren, Y., Houghton, P. J., & Hider, R. C. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.7.0015 · Cited by 51
Brain and brawn
Moreira, P. I., Honda, K., Zhu, X., Nunomura, A., Casadesús, G., Smith, M. A., & Perry, G. L. (2006) · Neurology · doi:10.1212/01.wnl.0000192307.15103.83 · Cited by 51
Elevated Zinc Transporter-6 in Mild Cognitive Impairment, Alzheimer Disease, and Pick Disease
Lovell, M. A., Smith, J. L., & Markesbery, W. R. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000229237.98124.91 · Cited by 51
Self-citation
1.4T study of proton magnetic relaxation rates, iron concentrations, and plaque burden in Alzheimer's disease and control postmortem brain tissue
House, M. J., Pierre, T. G. S., & McLean, C. (2008) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21586 · Cited by 51
Metal specificity of an iron-responsive element in Alzheimer’s APP mRNA 5′untranslated region, tolerance of SH-SY5Y and H4 neural cells to desferrioxamine, clioquinol, VK-28, and a piperazine chelator
Bandyopadhyay, S., Huang, X., Cho, H. K., Greig, N. H., Youdim, M. B. H., & Rogers, J. T. (2006) · Springer eBooks · doi:10.1007/978-3-211-33328-0_25 · Cited by 51
Elevated glutathione as a therapeutic strategy in Alzheimer's disease
Butterfield, D. A., Pocernich, C. B., & Drake, J. (2002) · Drug Development Research · doi:10.1002/ddr.10095 · Cited by 51
Coordination of copper(II) ions by the 11–20 and 11–28 fragments of human and mouse β-amyloid peptide
Kowalik‐Jankowska, T., Ruta-Dolejsz, M., Wiśniewska, K., & Łankiewicz, L. (2002) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(02)00495-6 · Cited by 51
Red blood cell copper, zinc superoxide dismutase activity is higher in Alzheimer's disease and is decreased by d-penicillamine
Rossi, L. C., Squitti, R., Pasqualetti, P., Marchese, E., Cassetta, E., Forastiere, E., Rotilio, G., Rossini, P. M., & Finazzi‐Agrò, A. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00599-2 · Cited by 51
Recent Development of Bifunctional Small Molecules to Study Metal‐Amyloid‐β Species in Alzheimer′s Disease
Braymer, J. J., DeToma, A. S., Choi, J.-S., Ko, K. S., & Lim, M. H. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/623051 · Cited by 50
“Elevated concentrations of Cu(II) and Zn(II) have been observed in senile plaques [1, 4, 13–15, 24, 25]; in particular, high concentrations of labile zinc are found in the regions of the brain most affected by AD, the cortex and hippocampus [4, 13–17, 19].”
Background
Longitudinal Consumption of Ergothioneine Reduces Oxidative Stress and Amyloid Plaques and Restores Glucose Metabolism in the 5XFAD Mouse Model of Alzheimer’s Disease
Whitmore, C. A., Haynes, J. R., Behof, W. J., Rosenberg, A. J., Tantawy, M. N., Hachey, B. C., Wadzinski, B. E., Spiller, B. W., Peterson, T. E., Paffenroth, K. C., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15060742 · Cited by 50
Longitudinal Analysis of Serum Copper and Ceruloplasmin in Alzheimer's Disease
Rembach, A., Doecke, J. D., Roberts, B. R., Watt, A. D., Faux, N. G., Volitakis, I., Pertile, K. K., Rumble, R. L., Trounson, B. O., Fowler, C. J., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121474 · Cited by 51
In vivo target bio-imaging of Alzheimer's disease by fluorescent zinc oxide nanoclusters
Lai, L., Zhao, C., Su, M., Li, X., Liu, X., Jiang, H., Amatore, C. A., & Wang, X. (2016) · Biomaterials Science · doi:10.1039/c6bm00233a · Cited by 50
Effects of Cu(II) on the aggregation of amyloid-β
Weibull, M. G. M., Simonsen, S., Oksbjerg, C. R., Tiwari, M. K., & Hemmingsen, L. (2019) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-019-01727-5 · Cited by 52
Ab initio modelling of the structure and redox behaviour of copper(I) bound to a His–His model peptide: relevance to the β-amyloid peptide of Alzheimer’s disease
Raffa, D. F., Rickard, G. A., & Rauk, A. (2006) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-006-0175-9 · Cited by 50
Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer's disease
Villemagne, V. L., Rowe, C. C., Macfarlane, S., Novakovic, K. E., & Masters, C. L. (2005) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2004.03.011 · Cited by 50
Tumor necrosis factor alpha–mediated nitric oxide production enhances manganese superoxide dismutase nitration and mitochondrial dysfunction in primary neurons: an insight into the role of glial cells
Tangpong, J., Sompol, P. M., Vore, M. E., Clair, W. H. S., Butterfield, D. A., & Clair, D. K. S. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.10.046 · Cited by 50
Selective Acetylcholinesterase Inhibitor Activated by Acetylcholinesterase Releases an Active Chelator with Neurorescuing and Anti-Amyloid Activities
Zheng, H., Youdim, M. B. H., & Fridkin, M. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn100069c · Cited by 50
Alzheimer's β-amyloid peptide as a source of neurotoxic free radicals: the role of structural effects
Pogocki, D. (2003) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2003-1463 · Cited by 50
Sources and mechanisms of cytoplasmic oxidative damage in Alzheimer's disease
Marlatt, M. W., Lee, H., Perry, G. L., Smith, M. A., & Zhu, X. (2004) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2004-1493 · Cited by 49
Copper‐Binding Peptides Attenuate Microglia Inflammation through Suppression of NF‐kB Pathway
Caetano‐Silva, M. E., Rund, L. A., Vailati-Riboni, M., Pacheco, M. T. B., & Johnson, R. W. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202100153 · Cited by 49
Aluminum exposure through the diet: Metal levels in AβPP transgenic mice, a model for Alzheimer's disease
Gómez, M., Esparza, J. L., Cabré, M., García, T. G., & Domingo, J. L. (2008) · Toxicology · doi:10.1016/j.tox.2008.05.004 · Cited by 49
Binding of iron(III) to the single tyrosine residue of amyloid β-peptide probed by Raman spectroscopy
Miura, T., Suzuki, K., & Takeuchi, H. (2001) · Journal of Molecular Structure · doi:10.1016/s0022-2860(01)00807-9 · Cited by 49
Increased expression of ferritin in cerebral cortex after human traumatic brain injury
Liu, H., Li, W., Chen, Z.-R., Zhou, M., Zhuang, Z., Zhang, D.-D., Zhu, L., & Hang, C. (2012) · Neurological Sciences · doi:10.1007/s10072-012-1214-7 · Cited by 49
Cerebral Amyloidosis: Postmortem Detection with Human 7.0-T MR Imaging System
van Rooden, S., Maat–Schieman, M. L. C., Nabuurs, R. J. A., van der Weerd, L., van Duijn, S., van Duinen, S. G., Natté, R., van Buchem, M. A., & van der Grond, J. (2009) · Radiology · doi:10.1148/radiol.2533090490 · Cited by 49
Inhibition of human high-affinity copper importer Ctr1 orthologous in the nervous system of Drosophila ameliorates Aβ42-induced Alzheimer's disease–like symptoms
Lang, M., Fan, Q., Wang, L., Zheng, Y., Xiao, G., Wang, X., Wang, W., Zhong, Y., & Zhou, B. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.05.029 · Cited by 51
Interaction of amyloid β peptides with redox active heme cofactor: Relevance to Alzheimer's disease
Pramanik, D., Ghosh, C., Mukherjee, S., & Dey, S. G. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.02.025 · Cited by 50
Ex vivo T2 relaxation: associations with age-related neuropathology and cognition
Dawe, R. J., Bennett, D. A., Schneider, J. A., Leurgans, S. E., Kotrotsou, A., Boyle, P. A., & Arfanakis, K. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.144 · Cited by 50
pH-dependence of the specific binding of Cu(II) and Zn(II) ions to the amyloid-β peptide
Ghalebani, L., Wahlström, A., Danielsson, J., Wärmländer, S. K. T. S., & Gräslund, A. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.04.043 · Cited by 48
Interdisciplinary challenges and promising theranostic effects of nanoscience in Alzheimer's disease
Laurent, S., Ejtehadi, M. R., Rezaei, M., Kehoe, P. G., & Mahmoudi, M. (2012) · RSC Advances · doi:10.1039/c2ra01374f · Cited by 51
Nucleic acid oxidative damage in Alzheimer's disease—explained by the hepcidin-ferroportin neuronal iron overload hypothesis?
Hofer, T., & Perry, G. L. (2016) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2016.06.005 · Cited by 49
Tripeptide GGH as the Inhibitor of Copper-Amyloid-β-Mediated Redox Reaction and Toxicity
Hu, X., Zhang, Q., Wang, W., Yuan, Z., Zhu, X., Chen, B., & Chen, X.-Y. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00145 · Cited by 49
Trace metal concentrations in hair and nails from Alzheimer’s disease patients: Relations with clinical severity
Köseoğlu, E., Köşeoğlu, R., Kendirci, M., Saraymen, R., & Saraymen, B. (2016) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2016.09.002 · Cited by 49
Functionalized poly (ionic liquid) as the support to construct a ratiometric electrochemical biosensor for the selective determination of copper ions in AD rats
Yu, Y., Yu, C., Yin, T., Ou, S., Sun, X., Wen, X., Zhang, L., Tang, D., & Yin, X. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.08.066 · Cited by 49
A novel fluorescent sensor based on imidazole derivative for Fe3+ ions
Kuzu, B., Tan, M., Ekmekci, Z., & Mengeş, N. (2017) · Journal of Luminescence · doi:10.1016/j.jlumin.2017.08.057 · Cited by 49
Serum and brain natural copper stable isotopes in a mouse model of Alzheimer’s disease
Moynier, F., Creech, J., Dallas, J., & Borgne, M. L. (2019) · Scientific Reports · doi:10.1038/s41598-019-47790-5 · Cited by 50
Natural compounds as inhibitors of transthyretin amyloidosis and neuroprotective agents: analysis of structural data for future drug design
Ciccone, L., Tonali, N., Nencetti, S., & Orlandini, E. (2020) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2020.1760262 · Cited by 49
The severity of cortical Alzheimer's type changes is positively correlated with increased amyloid-β Levels: Resolubilization of amyloid-β with transition metal ion chelators
Fonte, J., Miklossy, J., Atwood, C., & Martins, R. N. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3206 · Cited by 49
Modulation of Fibrillogenesis of Amyloid β(1−40) Peptide with Cationic Gemini Surfactant
Cao, M., Han, Y., Wang, J., & Wang, Y. (2007) · The Journal of Physical Chemistry B · doi:10.1021/jp075271b · Cited by 49
Amyloid β and neuromelanin—Toxic or protective molecules?The cellular context makes the difference
Rao, K. S. J., Hegde, M. L., Anitha, S., Musicco, M., Zucca, F. A., TURRO, N. J., & Zecca, L. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.03.004 · Cited by 49
Unraveling the Burden of Iron in Neurodegeneration: Intersections with Amyloid Beta Peptide Pathology
Uranga, R. M., & Salvador, G. A. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/2850341 · Cited by 48
Small Bifunctional Chelators That Do Not Disaggregate Amyloid β Fibrils Exhibit Reduced Cellular Toxicity
Sharma, A. K., Kim, J., Prior, J. T., Hawco, N. J., Rath, N. P., Kim, J., & Mirica, L. M. (2014) · Inorganic Chemistry · doi:10.1021/ic500926c · Cited by 48
Oxidative Stress in Alzheimer’s Disease: Molecular Hallmarks of Underlying Vulnerability
Uddin, M. S., & Kabir, M. T. (2019) · Springer eBooks · doi:10.1007/978-981-13-9636-6_5 · Cited by 50
Role of Nanomedicine-Based Therapeutics in the Treatment of CNS Disorders
Guo, Z.-H., Khattak, S., Rauf, M. A., Ansari, M. A., Alomary, M. N., Razak, S., Yang, C., Wu, D., & Ji, X. (2023) · Molecules · doi:10.3390/molecules28031283 · Cited by 49
The effect of iron in MRI and transverse relaxation of amyloid‐beta plaques in Alzheimer's disease
Meadowcroft, M. D., Peters, D. G., Dewal, R. P., Connor, J. R., & Yang, Q. X. (2014) · NMR in Biomedicine · doi:10.1002/nbm.3247 · Cited by 48
Advances in Nanomedicine for the Treatment of Alzheimer’s and Parkinson’s Diseases
Hernando, S., Gartziandia, O., Herrán, E., Pedraz, J. L., Igartúa, M., & Hernández, R. M. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0019 · Cited by 48
Zn2+ Aggravates Tau Aggregation and Neurotoxicity
Li, X., Du, X., & Ni, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030487 · Cited by 48
Copper and Zinc Promote Interactions between Membrane-Anchored Peptides of the Metal Binding Domain of the Prion Protein
Kenward, A. G., Bartolotti, L. J., & Burns, C. (2007) · Biochemistry · doi:10.1021/bi602473r · Cited by 48
A Novel Iron-Chelating Derivative of the Neuroprotective Peptide NAPVSIPQ Shows Superior Antioxidant and Antineurodegenerative Capabilities
Blat, D., Weiner, L. M., Youdim, M. B. H., & Fridkin, M. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070800l · Cited by 49
Effective switch-on fluorescence sensing of zinc(II) ion by 8-aminoquinolino-β-cyclodextrin/adamantaneacetic acid system in water
Chen, Y., Han, K.-Y., & Liu, Y. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.04.016 · Cited by 48
Novel Rivastigmine Derivatives as Promising Multi-Target Compounds for Potential Treatment of Alzheimer’s Disease
Vicente-Zurdo, D., Rosales-Conrado, N., León-González, M. E., Brunetti, L., Piemontese, L., Pereira-Santos, A. R., Cardoso, S. M., Madrid, Y., Chaves, S., & Santos, M. A. (2022) · Biomedicines · doi:10.3390/biomedicines10071510 · Cited by 47
“In fact, more than two decades ago several studies revealed the accumulation of metal ions, such as Fe(II), Cu(II) and Zn(II), in amyloid aggregates [14].”
Background
7T T2∗-weighted magnetic resonance imaging reveals cortical phase differences between early- and late-onset Alzheimer's disease
van Rooden, S., Doan, N. T., Versluis, M. J., Goos, J. D. C., WEBB, A. G., Oleksik, A. M., van der Flier, W. M., Scheltens, P., Barkhof, F., Weverling‐Rynsburger, A. W. E., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.006 · Cited by 47
Determination of Zn, Cu and Fe in human patients' serum using micro-sampling ICP-MS and sample dilution
Abduljabbar, T. N., Sharp, B. L., Reid, H. J., Barzegar-Befroei, N., Pető, T., & Lengyel, I. (2019) · Talanta · doi:10.1016/j.talanta.2019.05.098 · Cited by 49
Induction of cyclooxygenase-2 expression by manganese in cultured astrocytes
LIAO, S., OU, Y., Chen, S., CHIANG, A., & Chen, C. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.09.016 · Cited by 47
DHPA Protects SH-SY5Y Cells from Oxidative Stress-Induced Apoptosis via Mitochondria Apoptosis and the Keap1/Nrf2/HO-1 Signaling Pathway
Cai, Y., Xiao, R., Zhang, Y., Xu, D., Wang, N., Han, M., Zhang, Y., Zhang, L., & Zhou, W. (2022) · Antioxidants · doi:10.3390/antiox11091794 · Cited by 46
Revisiting the Role of Vitamins and Minerals in Alzheimer’s Disease
Shah, H., Dehghani, F., Ramezan, M., Gannaban, R. B., Haque, Z. F., Rahimi, F. C., Abbasi, S., & Shin, A. C. (2023) · Antioxidants · doi:10.3390/antiox12020415 · Cited by 48
Insights Into the Role of Copper in Neurodegenerative Diseases and the Therapeutic Potential of Natural Compounds
Zhong, G., Wang, X., Li, J., Xie, Z., Wu, Q., Chen, J., Wang, Y., Chen, Z., Cao, X., Li, T., et al. (2023) · Current Neuropharmacology · doi:10.2174/1570159x22666231103085859 · Cited by 49
Recent Advances in Targeting Transition Metals (Copper, Iron, and Zinc) in Alzheimer’s Disease
Singh, R., Panghal, A., Jadhav, K., Thakur, A., Verma, R. K., Singh, C., Goyal, M., Kumar, J., & Namdeo, A. G. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04256-8 · Cited by 50
Cu(II) enhances the effect of Alzheimer’s amyloid-β peptide on microglial activation
Yu, F., Gong, P., Hu, Z., Qiu, Y. L., Cui, Y., Gao, X., Chen, H., & Li, J. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0343-3 · Cited by 47
Alzheimer's Disease: Another Target for Heparin Therapy
Bergamaschini, L. C., Rossi, E., Vergani, C., & Simoni, M. G. D. (2009) · The Scientific World JOURNAL · doi:10.1100/tsw.2009.100 · Cited by 46
Thermal aggregation of β-lactoglobulin in presence of metal ions
Navarra, G., Leone, M., & Militello, V. (2007) · Biophysical Chemistry · doi:10.1016/j.bpc.2007.09.003 · Cited by 47
Structural insights into the interaction of platinum-based inhibitors with the Alzheimer's disease amyloid-β peptide
Streltsov, V. A., Epa, V. C., James, S., Churches, Q. I., Caine, J. M., Kenche, V. B., & Barnham, K. J. (2013) · Chemical Communications · doi:10.1039/c3cc47326k · Cited by 46
Decreased serum zinc is an effect of ageing and not Alzheimer's disease
Rembach, A., Hare, D. J., Doecke, J. D., Burnham, S. C., Volitakis, I., Fowler, C. J., Cherny, R. A., McLean, C., Grimm, R., Martins, R. N., et al. (2014) · Metallomics · doi:10.1039/c4mt00060a · Cited by 46
Proteomics of Alzheimer’s disease: understanding mechanisms and seeking biomarkers
Lovestone, S., Güntert, A., Hye, A., Lynham, S., Thambisetty, M., & Ward, M. A. (2007) · Expert Review of Proteomics · doi:10.1586/14789450.4.2.227 · Cited by 46
Intracellular amyloid formation in muscle cells of Aβ-transgenic Caenorhabditis elegans: determinants and physiological role in copper detoxification
Minniti, A. N., Rebolledo, D. L., Grez, P. M., Fadić, R., Aldunate, R., Volitakis, I., Cherny, R. A., Opazo, C., Masters, C. L., Bush, A. I., et al. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-2 · Cited by 46
Observation of Reduced Cytotoxicity of Aggregated Amyloidogenic Peptides with Chaperone-like Molecules
Liu, L., Zhang, L., Niu, L., Xu, M., Mao, X., Yang, Y., & Wang, C. (2011) · ACS Nano · doi:10.1021/nn201773x · Cited by 46
Iron in neurodegenerative disorders: being in the wrong place at the wrong time?
Apostolakis, S., & Kypraiou, A.-M. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0020 · Cited by 47
β-Synuclein: An Enigmatic Protein with Diverse Functionality
Hayashi, J., & Carver, J. A. (2022) · Biomolecules · doi:10.3390/biom12010142 · Cited by 50
Iron inhibits neurotoxicity induced by trace copper and biological reductants
White, A. R., Barnham, K. J., Huang, X., Volitakis, I., Beyreuther, K. T., Masters, C. L., Cherny, R. A., Bush, A. I., & Cappai, R. (2004) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-004-0521-8 · Cited by 46
Compensatory responses induced by oxidative stress in Alzheimer disease
Moreira, P. I., Zhu, X., Liu, Q., Honda, K., Siedlak, S. L., Harris, P. L. R., Smith, M. A., & Perry, G. L. (2006) · Biological Research · doi:10.4067/s0716-97602006000100002 · Cited by 45
Membrane interactions and the effect of metal ions of the amyloidogenic fragment Aβ(25–35) in comparison to Aβ(1–42)
Lau, T., Gehman, J. D., Wade, J. D., Perez, K. A., Masters, C. L., Barnham, K. J., & Separovic, F. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.05.004 · Cited by 46
Two pyridine derivatives as potential Cu( ii ) and Zn( ii ) chelators in therapy for Alzheimer's disease
Lakatos, A., Zsigó, É., Hollender, D., May, N. V., Fülöp, L., Simon, D., Bozsó, Z., & Kiss, T. (2009) · Dalton Transactions · doi:10.1039/b916366b · Cited by 46
Iron in Alzheimer’s Disease: From Physiology to Disease Disabilities
Pal, A., Cerchiaro, G., Rani, I., Ventriglia, M., Rongioletti, M. C. A., Longobardi, A., & Squitti, R. (2022) · Biomolecules · doi:10.3390/biom12091248 · Cited by 49
The secret life of extracellular vesicles in metal homeostasis and neurodegeneration
Bellingham, S. A., Guo, B. B., & Hill, A. F. (2015) · Biology of the Cell · doi:10.1111/boc.201500030 · Cited by 45
Metallo-pathways to Alzheimer's disease: lessons from genetic disorders of copper trafficking
Greenough, M. A., Muñoz, A. R., Bush, A. I., & Opazo, C. (2016) · Metallomics · doi:10.1039/c6mt00095a · Cited by 45
Aggregation of Microtubule Binding Repeats of Tau Protein is Promoted by Cu2+
Ahmadi, S., Zhu, S., Sharma, R., Wu, B. H., Soong, R., Majumdar, R. D., Wilson, D. J., Simpson, A. J., & Kraatz, H. (2019) · ACS Omega · doi:10.1021/acsomega.8b03595 · Cited by 45
Complex of EGCG with Cu(II) Suppresses Amyloid Aggregation and Cu(II)-Induced Cytotoxicity of α-Synuclein
Teng, Y., Zhao, J., Ding, L., Ding, Y., & Zhou, P. (2019) · Molecules · doi:10.3390/molecules24162940 · Cited by 47
Zinc Binding to Tau Influences Aggregation Kinetics and Oligomer Distribution
Moreira, G. G., Cristóvão, J. S., Torres, V. M., Carapeto, A. P., Rodrigues, M. S., Landrieu, I., CORDEIRO, C. A., & Gomes, C. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235979 · Cited by 44
Amentoflavone: A Bifunctional Metal Chelator that Controls the Formation of Neurotoxic Soluble Aβ 42 Oligomers
Sun, L., Sharma, A. K., Han, B.-H., & Mirica, L. M. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00376 · Cited by 46
The induction of amyloid precursor protein and α-synuclein in rat hippocampal astrocytes by diethyldithiocarbamate and copper with or without glutathione
Cheng, S. (2003) · Toxicology Letters · doi:10.1016/j.toxlet.2003.09.009 · Cited by 45
Glycosylated tetrahydrosalens as multifunctional molecules for Alzheimer's therapy
Storr, T., Scott, L. E., Bowen, M. L., Green, D. E., Thompson, K. H., Schugar, H. J., & Orvig, C. (2009) · Dalton Transactions · doi:10.1039/b902545f · Cited by 44
Differential alterations in antioxidant capacity in cells from Alzheimer patients
Gibson, G. E., Zhang, H., Sheu, K.-F. R., & Park, L. C. H. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00057-0 · Cited by 44
Cu K-edge X-ray absorption spectroscopy reveals differential copper coordination within amyloid-β oligomers compared to amyloid-β monomers
Shearer, J., Callan, P. E., Tran, T., & Szalai, V. A. (2010) · Chemical Communications · doi:10.1039/c0cc02446e · Cited by 44
Interaction of curcumin with Al(III) and its complex structures based on experiments and theoretical calculations
Jiang, T., Wang, L., Zhang, S., Sun, P., Ding, C., Chu, Y., & Zhou, P. (2011) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2011.07.059 · Cited by 45
Stabilization of native amyloid β-protein oligomers by Copper and Hydrogen peroxide Induced Cross-linking of Unmodified Proteins (CHICUP)
Williams, T. L., Serpell, L. C., & Urbanc, B. (2015) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2015.12.001 · Cited by 45
Copper Coordination to Native N-Terminally Modified versus Full-Length Amyloid-β: Second-Sphere Effects Determine the Species Present at Physiological pH
Aliès, B., Bijani, C., Sayen, S., Guillon, E., Faller, P., & Hureau, C. (2012) · Inorganic Chemistry · doi:10.1021/ic302097d · Cited by 44
Copper chelators promote nonamyloidogenic processing of Aβ PP via MT 1/2 / CREB ‐dependent signaling pathways in Aβ PP / PS 1 transgenic mice
Wang, Z., Zhang, Y., Zhang, W., Gao, H., Zhong, M., Huang, T., Guo, R., Liu, N., Li, D., Li, Y., et al. (2018) · Journal of Pineal Research · doi:10.1111/jpi.12502 · Cited by 44
The Molecular Dance of Fibronectin: Conformational Flexibility Leads to Functional Versatility
Mezzenga, R., & Mitsi, M. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.8b01258 · Cited by 44
Importance of Hydrogen Bonding: Structure–Activity Relationships of Ruthenium(III) Complexes with Pyridine-Based Ligands for Alzheimer’s Disease Therapy
Wall, B. J., Will, M. F., Yawson, G. K., Bothwell, P. J., Platt, D. C., Apuzzo, C. F., Jones, M. A., Ferrence, G. M., & Webb, M. I. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00360 · Cited by 44
Chitooligosaccharides Attenuate Cu2+-Induced Cellular Oxidative Damage and Cell Apoptosis Involving Nrf2 Activation
Huang, H., Hong, L., Chang, P., Zhang, J., Lu, S., Zheng, B.-W., & Jiang, Z.-F. (2014) · Neurotoxicity Research · doi:10.1007/s12640-014-9512-x · Cited by 44
Gene-Environment Interaction Research and Transgenic Mouse Models of Alzheimer's Disease (Erratum)
Chouliaras, L., Sierksma, A. S. R., Kenis, G., Prickaerts, J., Lemmens, M. A. M., Brasnjevic, I., van Donkelaar, E. L., Martínez‐Martínez, P., Losen, M. H., Baets, M. H. D., et al. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2010/356862 · Cited by 44
Differential profiles of copper-induced ROS generation in human neuroblastoma and astrocytoma cells
Qian, Y., Zheng, Y., Abraham, L., Ramos, K. S., & Tiffany‐Castiglioni, E. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.11.004 · Cited by 43
Molecular targeting of Alzheimer's amyloid plaques for contrast‐enhanced magnetic resonance imaging
Poduslo, J. F., Wengenack, T. M., Curran, G. L., Wısnıewskı, T., Sigurdsson, E. M., Macura, S. I., Borowski, B., & Jack, C. R. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.81.s1.20_5.x · Cited by 43
Calorimetric investigation of copper(II) binding to Aβ peptides: thermodynamics of coordination plasticity
Sacco, C., Skowronsky, R. A., Gade, S., Kenney, J. M., & Spuches, A. M. (2012) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-012-0874-3 · Cited by 42
Links between copper and cholesterol in Alzheimer's disease
Hung, Y. H., Bush, A. I., & Fontaine, S. L. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00111 · Cited by 44
Soluble Amyloid β1−28−Copper(I)/Copper(II)/Iron(II) Complexes Are Potent Antioxidants in Cell-Free Systems
Baruch-Suchodolsky, R., & Fischer, B. (2008) · Biochemistry · doi:10.1021/bi800114g · Cited by 44
Copper Reduces A Oligomeric Species and Ameliorates Neuromuscular Synaptic Defects in a C. elegans Model of Inclusion Body Myositis
Rebolledo, D. L., Aldunate, R., Kohn, R., Neira, I., Minniti, A. N., & Inestrosa, N. C. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0336-11.2011 · Cited by 42

Authors: Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R.
Affiliations: University of Kentucky (US)
University of Guelph (CA)
ORCID: Lovell, M.A
Robertson, J.D
Venue: Journal of the Neurological Sciences
Publisher: Elsevier BV
Published: 1998-06
Volume: 158
Issue: 1
Pages: 47-52
ISSN: 0022-510X (ISSN-L)
DOI: 10.1016/s0022-510x(98)00092-6
OpenAlex: W2083500052
Cited by: 2,120
References: 72
Citations by year: 2026: 38 · 2025: 52 · 2024: 69 · 2023: 82 · 2022: 100 · 2021: 92 · 2020: 95 · 2019: 103 · 2018: 80 · 2017: 94 · 2016: 87 · 2015: 82 · 2014: 89 · 2013: 96 · 2012: 116
FWCI: 18.64
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Journal of the Neurological Sciences (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Aging (2-PO1-AG05119, P01AG005119, 5-P50 AG0514)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: Alzheimer's disease, amyloid plaques, copper, iron, zinc, trace elements, amygdala, amyloid-beta aggregation, neuropil
MeSH terms: Alzheimer Disease, Amygdala, Copper, Humans, Iron, Spectrometry, X-Ray Emission, Zinc, Neuropil, Biotinylation, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Copper, iron and zinc in Alzheimer's disease senile plaques

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks